Evidence map›Paper›PMID 41052414›Full record

ArticleBlood advances2025

Time to redefine HHV-8 MCD and KICS criteria?

Romain Stammler, Yannick Dieudonné, Anthony Vanjak, Eric Oksenhendler, Lionel Galicier, David Boutboul

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Romain StammlerLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Université Paris Cité, Paris, France.
Yannick DieudonnéDepartment of Clinical Immunology and Internal Medicine, Strasbourg University Hospital, Strasbourg, France.
Anthony VanjakCircuit Ambulatoire de Symptômes Persistants au COVID Unit, Department of Internal Medicine, Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.ORCID 0000-0002-9288-3386
Eric OksenhendlerNational Reference Center for Castleman disease, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.ORCID 0000-0001-8588-7138
Lionel GalicierNational Reference Center for Castleman disease, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.ORCID 0000-0002-0360-7620
David BoutboulLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Université Paris Cité, Paris, France.ORCID 0000-0002-5006-8279

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41052414
PMCPMC12848352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.